Abstract
Rheumatoid arthritis (RA) presents a number of challenges to both patients and physicians. Because primary care physicians (PCPs) treat most patients who have musculoskeletal disorders, they have an important role in the management of RA, particularly in early diagnosis and treatment. Familiarity with the use of disease-modifying antirheumatic drugs (DMARDs) and combination DMARDs as the cornerstones of therapy is essential. PCPs are also in the best position to monitor comorbid disease. Given the potentially devastating complications of RA, disease management requires a comprehensive approach that includes referrals of patients with significant disease comorbidity to rheumatologic specialists.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 23-28 |
| Number of pages | 6 |
| Journal | Drug Benefit Trends |
| Volume | 16 |
| Issue number | SUPPL. C |
| State | Published - Jun 1 2004 |
Fingerprint
Keywords
- Cyclooxygenase inhibitors
- Disease-modifying antirheumatic drugs
- Methotrexate
- NSAIDs
- Tumor necrosis factor inhibitors
ASJC Scopus subject areas
- Health Policy
- Pharmacology (medical)
Cite this
Managing rheumatoid arthritis in the primary care setting. / Mikuls, Ted R; O'Dell, James Robert.
In: Drug Benefit Trends, Vol. 16, No. SUPPL. C, 01.06.2004, p. 23-28.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Managing rheumatoid arthritis in the primary care setting
AU - Mikuls, Ted R
AU - O'Dell, James Robert
PY - 2004/6/1
Y1 - 2004/6/1
N2 - Rheumatoid arthritis (RA) presents a number of challenges to both patients and physicians. Because primary care physicians (PCPs) treat most patients who have musculoskeletal disorders, they have an important role in the management of RA, particularly in early diagnosis and treatment. Familiarity with the use of disease-modifying antirheumatic drugs (DMARDs) and combination DMARDs as the cornerstones of therapy is essential. PCPs are also in the best position to monitor comorbid disease. Given the potentially devastating complications of RA, disease management requires a comprehensive approach that includes referrals of patients with significant disease comorbidity to rheumatologic specialists.
AB - Rheumatoid arthritis (RA) presents a number of challenges to both patients and physicians. Because primary care physicians (PCPs) treat most patients who have musculoskeletal disorders, they have an important role in the management of RA, particularly in early diagnosis and treatment. Familiarity with the use of disease-modifying antirheumatic drugs (DMARDs) and combination DMARDs as the cornerstones of therapy is essential. PCPs are also in the best position to monitor comorbid disease. Given the potentially devastating complications of RA, disease management requires a comprehensive approach that includes referrals of patients with significant disease comorbidity to rheumatologic specialists.
KW - Cyclooxygenase inhibitors
KW - Disease-modifying antirheumatic drugs
KW - Methotrexate
KW - NSAIDs
KW - Tumor necrosis factor inhibitors
UR - http://www.scopus.com/inward/record.url?scp=3042592872&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3042592872&partnerID=8YFLogxK
M3 - Review article
AN - SCOPUS:3042592872
VL - 16
SP - 23
EP - 28
JO - Drug Benefit Trends
JF - Drug Benefit Trends
SN - 1080-5826
IS - SUPPL. C
ER -